Intravenous ketamine therapy in a patient with a treatment-resistant major depression

Intravenous ketamine therapy in a patient with a treatment-resistant major depression

Bibliographic Details
Main Authors:	M Liebrenz, A Borgeat, R Leisinger
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2007-04-01
Series:	Swiss Medical Weekly
Subjects:	Ketamine Depression
Online Access:	https://www.smw.ch/index.php/smw/article/view/722

Similar Items

Comparative Effect of Intravenous Ketamine and Electroconvulsive Therapy in Major Depression: A Randomized Controlled Trial
by: Gholamreza Kheirabadi, et al.
Published: (2019-01-01)

Intravenous Ketamine Therapy vs. Electroconvulsive Therapy in Depressive Cases
by: Gholam Reza Kheirabadi, et al.
Published: (2012-01-01)

Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada
by: Carson Chrenek, et al.
Published: (2024-01-01)

Efficacy of Electroconvulsive Therapy and Ketamine Therapy in Major Depressive Disorder; A Comparative Study
by: Asif Azeem Bajwa, et al.
Published: (2023-02-01)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
by: Natalia Górska, et al.
Published: (2021-05-01)

Case series of intravenous ketamine infusion in patients with suicidal thought
by: Pankaj Sharma, et al.
Published: (2023-01-01)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
by: Maria Gałuszko-Węgielnik, et al.
Published: (2023-01-01)

Effect of Pretreatment of S-Ketamine On Postoperative Depression for Breast Cancer Patients
by: Peirong Liu, et al.
Published: (2021-07-01)

Biweekly vs Triweekly low dose intravenous ketamine acute series for severe major depression: A case report
by: Hernandorena Carolina, et al.
Published: (2023-12-01)

The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
by: Brittany O’Brien, et al.
Published: (2019-09-01)

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
by: Ryan Yip, et al.
Published: (2022-09-01)

Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
by: F Kheirkhah, et al.
Published: (2010-10-01)

Comparison of two anesthetic induction methods:ketamin and thiopental Na for ECT in major depression disorder patients
by: Ali Barkhori, et al.
Published: (2014-05-01)

Impact comparison of ketamine and sodium thiopental on anesthesia during electroconvulsive therapy in major depression patients with drug-resistant; a double-blind randomized clinical trial
by: B Salehi, et al.
Published: (2015-01-01)

How effective are ketamine or esketamine in treatment-resistant depression?
by: N. Veluri, et al.
Published: (2021-04-01)

Ketamine for the treatment of major depression: a systematic review and meta-analysisResearch in context
by: Stevan Nikolin, et al.
Published: (2023-08-01)

Intramuscular ketamine in acute depression: A case report
by: C Harihar
Published: (2011-01-01)

Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
by: Minna Chang, et al.
Published: (2024-01-01)

Anhedonia and depression severity measures during ketamine administration in treatment-resistant depression
by: Aleksander Kwaśny, et al.
Published: (2024-02-01)

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder
by: Maria Gałuszko-Wȩgielnik, et al.
Published: (2023-07-01)

Do baseline anxiety symptoms impact response to IV Ketamine in treatment resistant depression?
by: Zoe Schreiber, et al.
Published: (2021-12-01)

Efficacy of different doses of ketamine as a bolus in major depressive disorder
by: Farzan Kheirkhah, et al.
Published: (2018-05-01)

Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series
by: Hewa Artin, et al.
Published: (2022-06-01)

Sustaining the benefits of intravenous ketamine with behavioural activation therapy for depression: A case series
by: Jennifer L. Phillips, et al.
Published: (2023-12-01)

Anti-inflammatory effects of ketamine in the treatment-resistant depression: a narrative review
by: Marta Elżbieta Jóźwiak-Bębenista, et al.
Published: (2024-02-01)

Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report
by: Boney Joseph, et al.
Published: (2023-08-01)

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
by: Wei Zheng, et al.
Published: (2021-12-01)

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
by: Alina Wilkowska, et al.
Published: (2022-11-01)

A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment‐resistant depression
by: Terry Schwartz, et al.
Published: (2021-05-01)

Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment
by: Artemis Zavaliangos-Petropulu, et al.
Published: (2023-10-01)

EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
by: Muhammad Siddique Kakar, et al.
Published: (2020-10-01)

EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
by: Muhammad Siddique Kakar, et al.
Published: (2020-10-01)

Ketamine study: Protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation
by: Ana Paula Anzolin, et al.
Published: (2023-03-01)

The Effect of Intravenous Ketamine on Suicidal Ideation in Depressed Patients: A Randomized Clinical Trial
by: Farah Moayedi, et al.
Published: (2023-07-01)

A unique case of very low‐dose subcutaneous ketamine use: Maintenance option of ketamine for treatment‐resistant depression
by: Adem T. Can, et al.
Published: (2022-12-01)

Erratum: Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment
by: Frontiers Production Office
Published: (2024-01-01)

Subcutaneous Ketamine in Depression: A Systematic Review
by: Vitor Breseghello Cavenaghi, et al.
Published: (2021-05-01)

Safety of Repeated Administration of Parenteral Ketamine for Depression
by: David Feifel, et al.
Published: (2020-07-01)

Role of the Pharmacist in Managing Treatment-Resistant Depression: A Focus on Ketamine
by: Linda Xing Yu Liu, et al.
Published: (2021-06-01)

Acute antidepressant effects of intramuscular versus intravenous ketamine
by: Harihar Chilukuri, et al.
Published: (2014-01-01)